Beyond Compliance: How VIP is Transforming MedTech Quality & Innovation
An Interview with MDIC's Joe Sapiente and Simon Rollison, Chief Operating Officer at ISACA.
Achieving enterprise-wide quality requires more than just compliance—it demands a culture of continuous improvement. The Voluntary Improvement Program (VIP), developed by industry for industry in collaboration with MDIC, ISACA, and the FDA, is transforming how manufacturers enhance speed to market, reduce risk, and improve patient outcomes.
With a data-driven, third-party appraisal approach tailored to companies of all sizes, VIP provides actionable insights that drive operational excellence. Organizations that participate see tangible benefits, including improved key performance metrics, higher renewal rates, and greater overall satisfaction.
Discover how VIP can help your company stay ahead by fostering innovation, ensuring product consistency, and strengthening your quality systems beyond regulatory requirements.
Presented By:
Joseph Sapiente
Chief Science and Technology Officer, MDIC
Simona Rollinson
Chief Operating Officer, ISACA